Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/25537
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBOUBEKRI, Nada Hanaa-
dc.contributor.authorZOUAD, Lynda.-
dc.date.accessioned2023-10-11T12:40:07Z-
dc.date.available2023-10-11T12:40:07Z-
dc.date.issued2023-
dc.identifier.urihttps://di.univ-blida.dz/jspui/handle/123456789/25537-
dc.description4.540.1.1086/p89fr_FR
dc.description.abstractHypertension, is a major risk factor for cardiovascular diseases. Rapidly lowering blood pressure to normal levels is effective in reducing the risks of these diseases. Therefore, the oral administration of drugs through thin films is a better alternative in such cases. This method also offers an alternative to conventional treatments for inflammation, providing improved bioavailability and easier administration. In this study, the development of Oral Dissolving Films (ODF) using the solvent casting/evaporation method was explored for administering acebutolol hydrochloride, an antihypertensive drug, and diclofenac sodium, an anti-inflammatory drug. Physicochemical characterizations of the ODFs revealed an increase in the dissolution rate and extent of acebutolol and diclofenac. The oral films are evaluated for dimensions, disintegration, tensile strength, stability and folding endurance. These ODFs have numerous applications, such as taste masking and immediate release. Additionally, these systems can be easily applied on their own.fr_FR
dc.language.isofrfr_FR
dc.publisherblida 1fr_FR
dc.subjectHypertension, Inflammation, Oral Dissolving Films (ODF), Immediate release.fr_FR
dc.titleFormulation et optimisation des films orodispersibles (ODF) pour le traitement de l’hypertension artérielleet de l’inflammation.fr_FR
dc.typeOtherfr_FR
Appears in Collections:Mémoires de Master

Files in This Item:
File Description SizeFormat 
123.pdf2,46 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.